Changes in the resistance and epidemiological characteristics of Pseudomonas aeruginosa during a ten-year period.

[1]  M. Jiang,et al.  Antibiotic prescribing practices in secondary and tertiary hospitals in Shaanxi province, western China, 2013-2015 , 2018, PloS one.

[2]  E. Brown,et al.  Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system , 2018, The Journal of antimicrobial chemotherapy.

[3]  A. Oliver,et al.  Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegansPseudomonas aeruginosa Infection Model , 2017, Antimicrobial Agents and Chemotherapy.

[4]  J. Rajkovic,et al.  Differences in antimicrobial consumption, prescribing and isolation rate of multidrug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii on surgical and medical wards , 2017, PloS one.

[5]  F. Guo,et al.  Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center , 2016, BMC Infectious Diseases.

[6]  H. Samadi kafil,et al.  Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[7]  M. Zou,et al.  Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China , 2016, Annals of Clinical Microbiology and Antimicrobials.

[8]  B. Jia,et al.  Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  S. Jeong,et al.  Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa , 2015, Infection & chemotherapy.

[10]  Weijun Chen,et al.  NDM-1 encoded by a pNDM-BJ01-like plasmid p3SP-NDM in clinical Enterobacter aerogenes , 2015, Front. Microbiol..

[11]  M. Surette,et al.  Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response , 2015, BMC Infectious Diseases.

[12]  C. Arias,et al.  Dissemination of High-Risk Clones of Extensively Drug-Resistant Pseudomonas aeruginosa in Colombia , 2015, Antimicrobial Agents and Chemotherapy.

[13]  S. Aaron,et al.  Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations , 2014, Journal of Cystic Fibrosis.

[14]  Ronald N. Jones,et al.  Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. , 2014, The Journal of antimicrobial chemotherapy.

[15]  I. Ciftci,et al.  The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa , 2014, World journal of microbiology & biotechnology.

[16]  T. Pirzadeh,et al.  Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  Y. Lu,et al.  Dissemination of IMP-6-producing Pseudomonas aeruginosa ST244 in multiple cities in China , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  A. Oliver,et al.  Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection , 2013, PloS one.

[19]  Robert E W Hancock,et al.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. , 2013, Pathogens and disease.

[20]  J. Fothergill,et al.  Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections , 2012, European Respiratory Journal.

[21]  M. Maciá,et al.  Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study , 2011, Antimicrobial Agents and Chemotherapy.

[22]  A. Oliver,et al.  Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals , 2007, Antimicrobial Agents and Chemotherapy.

[23]  Richard J Zeckhauser,et al.  Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States , 2006, Globalization and health.

[24]  H. Grundmann,et al.  Development of a Multilocus Sequence Typing Scheme for the Opportunistic Pathogen Pseudomonas aeruginosa , 2004, Journal of Clinical Microbiology.

[25]  S. Levy,et al.  The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. , 2002, The Journal of antimicrobial chemotherapy.